Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews

被引:7
|
作者
Studzinski, Krzysztof [1 ]
Tomasik, Tomasz [1 ]
Krzyszton, Janusz [1 ]
Jozwiak, Jacek [2 ]
Windak, Adam [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Family Med, Chair Internal Med & Gerontol, Krakow, Poland
[2] Czestochowa Tech Univ, Inst Hlth & Nutr Sci, Czestochowa, Poland
来源
BMJ OPEN | 2017年 / 7卷 / 03期
关键词
CORONARY-HEART-DISEASE; VALIDATION; STRATEGIES; DERIVATION; SCORES; IMPACT; CHART;
D O I
10.1136/bmjopen-2016-014206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Major clinical practice guidelines recommend assessing risk of cardiovascular disease (CVD) using absolute/global/total CVD risk scores. However, the effectiveness of using them in clinical practice, despite publication of numerous randomised controlled trials (RCTs), is still poorly understood. To summarise and analyse current knowledge in this field, we will carry out an overview of existing systematic reviews (SRs). The objective of this overview will be to assess the effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of CVD compared with standard care. Methods and analysis: We will include SRs and meta-analyses which take into account RCTs and quasi-RCTs investigating the effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of CVD. SRs will be retrieved from 4 bibliographical databases and reference lists of identified reviews. Additionally, the PROSPERO database will be searched for unpublished, ongoing or recently completed SRs. 2 reviewers will assess the SRs independently for eligibility and bias. The data will be extracted to a special form. Any disagreement will be resolved by discussion. In case of lack of consensus, a third author will arbitrate. The overview of SRs will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. Ethics and dissemination: Ethics approval is not required for overview of SRs. We will summarise evidence concerning whether use of the absolute/ global/total CVD risk scoring tools in primary prevention of CVD is effective and supported with scientific data or not. If we face unsatisfactory confirmation, we will highlight a need for further research and advice on how to plan such a study. We will submit the results of our study for peer-review publication in a journal indexed in the international bibliographic database of biomedical information.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] A simple risk score using routine data for predicting cardiovascular disease in primary care
    Chamnan, Parinya
    Simmons, Rebecca K.
    Hori, Hiroyuki
    Sharp, Stephen
    Khaw, Kay-Tee
    Wareham, Nicholas J.
    Griffin, Simon J.
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2010, 60 (577): : e327 - e334
  • [42] Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases
    Rosolova H.
    Nussbaumerova B.
    [J]. EPMA Journal, 2011, 2 (1): : 15 - 26
  • [43] THE BIOIMAGE STUDY: NOVEL APPROACHES TO RISK ASSESSMENT IN THE PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Muntendam, P.
    Gardiner, P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [44] Assessment of Cardiovascular Disease Risk
    Goldsborough III, Earl
    Osuji, Ngozi
    Blaha, Michael J.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (03) : 483 - 509
  • [45] Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews
    van Leeuwen, Marina T.
    Luu, Steven
    Gurney, Howard
    Brown, Martin R.
    Webber, Kate
    Pearson, Sallie-Anne
    Hunt, Lee
    Vajdic, Claire M.
    [J]. BMJ OPEN, 2018, 8 (06):
  • [46] Primary care prevention of cardiovascular risk behaviors in adolescents: A systematic review
    Tissot, Herve
    Pfarrwaller, Eva
    Haller, Dagmar M.
    [J]. PREVENTIVE MEDICINE, 2021, 142
  • [47] Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies
    Jeras, Jernej
    Ugovsek, Sabina
    Likozar, Andreja Rehberger
    Sebestjen, Miran
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (12)
  • [48] Cardiovascular Disease Risk Assessment and Prevention Current Guidelines and Limitations
    Alagona, Peter, Jr.
    Ahmad, Tariq Ali
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (04) : 711 - +
  • [49] Cardiovascular Disease (CVD) Risk Assessment and Prevention for Blood Donors
    Grima, K. M.
    Kessler, D.
    Valinsky, J.
    Ortiz, C.
    Kusick, M. A.
    Nandi, V.
    Vlahov, D.
    Ompad, D.
    Hillyer, C. D.
    [J]. TRANSFUSION, 2010, 50 : 33A - 34A
  • [50] The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women
    Priya M. Freaney
    Sadiya S. Khan
    Donald M. Lloyd-Jones
    Neil J. Stone
    [J]. Current Atherosclerosis Reports, 2020, 22